查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1944422

全球出血性中風治療器械市場：按器械類型、中風類型、手術類型、最終用戶、國家和地區分類－產業分析、市場規模、佔有率和預測（2025-2032年）

Hemorrhagic Stroke Treatment Devices Market, By Device Type, By Stroke Type, By Procedure Type, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 327 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2024 年，出血性中風治療設備市場規模將達到 10.8423 億美元，從 2025 年到 2032 年，複合年成長率將達到 7.12%。

出血性中風治療器械市場專注於用於治療出血性中風的醫療設備，主要包括腦出血、蜘蛛網膜下腔出血和腦動脈瘤破裂。這些事件被視為醫療急症，器械的選擇會影響止血速度、預防再出血以及病患的復健進程。此市場涵蓋血管內介入器械（例如彈簧圈、血流導引裝置和支架輔助系統），用於從血管內部封閉動脈瘤；以及外科手術器械，例如動脈瘤夾，用於必要時開顱手術。

需求與人口老化、高血壓和血管風險以及介入神經放射學醫院數量的增加等因素有關。該市場的採購決策通常基於臨床結果、安全性和併發症率、在複雜解剖結構中的易用性、與現有醫院系統的兼容性以及每次治療的總成本，而產品性能和證據是供應商之間競爭的關鍵因素。

出血性中風治療器材的市場動態

卒中負擔日益加重以及卒中中心就診便利性的提高，正在推動出血性卒中治療設備的廣泛應用。

出血性中風治療器械市場的主要促進因素是中風負擔的持續加重和中風診療體系的穩步擴展，這促使越來越多的患者前往能夠進行動脈瘤修復和其他神經血管手術的醫院就診。在美國，卒中仍然是一個重要的公共衛生問題：根據美國疾病管制與預防中心 (CDC) 發布的《2023-2024 年卒中最新情況報告》，卒中每年影響數十萬人，是導致長期殘疾的主要原因之一，這促使醫院繼續致力於改善急性卒中診療路徑和臨床療效。在全球範圍內，卒中對死亡率的影響仍然很高。根據世界衛生組織 (WHO) 發布的《2022-2024 年卒中最新情況報告》，卒中是全球主要死因之一，高血壓和人口老化仍然是其危險因子。系統性變革也至關重要，因為診療路徑和醫療網路會影響現有醫療機構的手術量。根據美國聯邦和州公共衛生/緊急醫療服務（EMS）卒中系統2020年至2024年收集的數據（包括HRSA支持的和各州卒中項目報告），越來越多的地區正在加強卒中分診和轉診通訊協定，並將重症卒中病例集中到卓越中心。這些中心使用血管內和外科器械的比例較高。對於醫院採購負責人和介入神經放射學團隊而言，這直接增加了對彈簧圈、血流導向裝置、支架和夾閉系統的需求，這些器械有助於降低再出血風險、提高手術安全性並縮短ICU和住院時間。

出血性中風治療設備市場：細分分析

導管介入治療路徑正日益普及，尤其是在動脈瘤相關出血方面，因為這種路徑允許患者在專科中心快速接受治療，並在許多情況下減輕開顱手術的負擔。總體而言，患者數量仍然龐大：根據美國疾病管制與預防中心 (CDC) 發布的 2023-2024 年卒中最新數據，美國每年有數十萬人發生卒中，這維持了活躍的卒中急救流程和充足的神經血管介入器械供應，以應對複雜的病例。隨著卒中系統不斷完善路徑和醫療網路，就醫途徑也持續改善。根據 2020-2024 年各州衛生部門中風系統計畫和急診轉診通訊協定更新，越來越多的地區正在實施結構化的分流規則，將重症中風患者轉診至高水準的中風中心。這導致符合血管內修復（使用彈簧圈、支架和血流導向技術）條件的出血性中風病例數量增加。從採購方面來看，這推動了對能夠應對複雜解剖結構、簡化手術流程、減少延長加護病房(ICU) 住院時間的併發症的設備的需求。

臨床需求也會因出血發生在腦組織內部還是周圍而有所不同，這會影響所需器械的類型和最終治療的速度。全球疾病負擔依然沉重：根據世界衛生組織（WHO，2022-2024 年更新）的數據，中風仍然是全球首要死因，而高血壓和人口老化等長期因素加劇了中風的高風險。醫院工作流程的壓力促使醫院加快診斷和治療準備。根據美國醫療保險和醫療補助服務中心（CMS）發布的 2020-2024 年住院品質計畫更新報告，醫院在持續品管和報告要求下運營，這強化了標準化的急性護理流程。這推動了對中風團隊能力的投入，並確保手術器械隨時可用。對於醫院董事會和介入神經放射學團隊而言，這通常意味著需要能夠提高動脈瘤固定速度和一致性、降低再出血風險和手術相關併發症的器械平台。

出血性中風治療設備市場—區域分析

從區域層面來看，擁有完善的中風網路和足夠多的專科醫院（提供全天候介入神經放射學服務）的醫療系統，對出血性中風治療設備的需求可能會更高。北美和歐洲部分地區普遍受益於完善的分診系統以及醫院對先進手術的積極投資。同時，亞太地區擁有龐大的病患群體，主要城市的先進醫院能力也不斷提升。臨床需求的規模仍然是關鍵的根本促進因素：根據美國疾病管制與預防中心（CDC，2023-2024 年更新數據），美國每年發生數十萬例中風，這支撐了具備卒中診療能力的醫院對動脈瘤修復工具和其他神經血管器械的穩定需求。全球範圍內的負擔依然沉重：根據世界衛生組織（WHO，2022-2024 年更新數據），卒中仍然是全球主要死因之一，長期給急救醫療系統和用於治療嚴重出血事件的器械帶來巨大壓力。

美國出血性中風治療器材市場—國家分析

美國憑藉其龐大的規模、強大的報銷能力以及龐大的醫院網路，成為領先的國內市場，這些醫院能夠保持卒中救治能力並實施新的血管內治療技術。高昂的卒中負擔持續推動著治療工作：根據美國疾病管制與預防中心（CDC）發布的《2023-2024年卒中最新報告》，卒中仍然是導致嚴重殘疾的主要原因之一，每年影響數十萬人。這持續推動醫院對快速診斷和介入治療能力的投資。醫院的獎勵和工作流程標準也影響採購。根據美國醫療保險和醫療補助服務中心（CMS）發布的《2020-2024年住院支付和品質計劃最新報告》，醫院在持續報告和績效考核的背景下運營，並正在加強標準化的急性卒中診療路徑。這推動了醫院採購治療出血性中風所需的血管內設備和手術器械。

目錄

第1章 出血性中風治療設備市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：出血性中風治療設備的主要市場趨勢

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 未來市場趨勢

第4章 出血性中風治療設備市場：產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長展望：概覽
  • 管理體制分析

第5章 出血性中風治療器材市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章 出血性中風治療器材的市場現狀

  • 出血性中風治療設備市場佔有率分析（2024 年）
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

7. 出血性中風治療設備市場（依設備類型分類）

  • 概述
    • 細分市場佔有率分析：依設備類型分類
    • 動脈瘤栓塞裝置
    • 分流器
    • 動脈瘤夾
    • 支架輔助栓塞系統
    • 抽吸和血栓清除系統

8. 依中風類型分類的出血性中風治療設備市場

  • 概述
    • 細分市場佔有率分析：依中風類型分類
    • 腦出血（ICH）
    • 蛛網膜下腔出血（SAH）

9. 出血性中風治療器械市場（依手術類型分類）

  • 概述
    • 細分市場佔有率分析：依手術類型
    • 血管內治療
    • 手術

第10章 依最終用戶分類的出血性中風治療設備市場

  • 概述
    • 細分市場佔有率分析：依最終用戶分類
    • 醫院
    • 專科診所
    • 門診手術中心

第11章 出血性中風治療設備市場（按地區分類）

  • 介紹
  • 北美洲
    • 概述
    • 北美主要製造商
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲主要製造商
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 其他
  • 亞太地區
    • 概述
    • 亞太地區主要製造商
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 其他
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲的主要製造商
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他

第12章 主要供應商分析－出血性中風治療設備產業

  • 競爭對手儀錶板
    • 競爭基準
    • 競爭定位
  • 公司簡介
    • Abbott Laboratories
    • B. Braun SE
    • Balt USA, LLC
    • Boston Scientific Corporation
    • Cook Medical LLC
    • Integer Holdings Corporation
    • Johnson &Johnson Services, Inc.
    • Kaneka Corporation
    • Medtronic plc
    • Merit Medical Systems, Inc.
    • MicroVention, Inc.
    • Natus Medical Incorporated
    • Nihon Kohden Corporation
    • Penumbra, Inc.
    • Phenox GmbH
    • Rapid Medical Ltd.
    • Stryker Corporation
    • Terumo Corporation
    • WL Gore &Associates, Inc.
    • Wallaby Medical Holding, Inc.
    • Others

第13章：分析師視角360度分析

簡介目錄
Product Code: ANV6063

Hemorrhagic Stroke Treatment Devices Market size was valued at US$ 1,084.23 Million in 2024, expanding at a CAGR of 7.12% from 2025 to 2032.

The hemorrhagic stroke treatment devices market focuses on medical devices used to manage bleeding-type strokes, mainly intracerebral hemorrhage and subarachnoid hemorrhage, including cases linked to ruptured brain aneurysms. These events are treated as medical emergencies, and the choice of devices can affect how quickly bleeding is controlled, whether re-bleeding is prevented, and how patients recover over time. The market includes endovascular tools such as coils, flow diverters, and stent-assisted systems used to seal aneurysms from inside the blood vessel, along with surgical tools like aneurysm clips used in open procedures when required.

Demand is connected to factors such as aging populations, high blood pressure and vascular risk, and the expansion of hospitals with neurointerventional capabilities. Buying decisions in this market are usually based on clinical outcomes, safety and complication rates, how easy devices are to use in complex anatomy, compatibility with existing hospital systems, and the overall cost per treated case, which makes product performance and evidence an important part of vendor competition.

Hemorrhagic Stroke Treatment Devices Market- Market Dynamics

High Stroke Burden and Better Access to Stroke Centers Are Increasing Use of Hemorrhagic Treatment Devices

A major driver for the hemorrhagic stroke treatment devices market is the ongoing stroke burden and the steady expansion of organized stroke care, which increases the number of patients reaching hospitals that can perform aneurysm repair and other neurovascular procedures. Stroke remains a major public health issue in the U.S.: According to the U.S. Centers for Disease Control and Prevention (CDC, stroke updates published during 2023-2024), stroke affects hundreds of thousands of people each year and continues to rank among the leading causes of long-term disability, which keeps hospitals focused on improving acute stroke pathways and clinical outcomes. Globally, the overall mortality impact stays high: According to World Health Organization (WHO) updates released during 2022-2024, stroke remains among the top causes of death worldwide, with hypertension and aging populations continuing to support risk levels. System changes also matter because routing and treatment networks influence procedure volume at capable sites: According to U.S. government and state public health/EMS stroke-system materials compiled across 2020-2024 (including HRSA-supported and state stroke program reporting), more regions have strengthened stroke triage and destination protocols, which increases the concentration of severe stroke cases at higher-level centers where endovascular and surgical device use is more common. For hospital buyers and neurointerventional teams, this directly supports demand for coils, flow diverters, stents, and clipping systems that can reduce re-bleeding risk, improve procedural safety, and help shorten ICU and hospital stays.

Hemorrhagic Stroke Treatment Devices Market- Segmentation Analysis:

More hemorrhagic stroke care is moving toward catheter-based treatment pathways, especially for aneurysm-related bleeding, because these procedures can be performed faster in specialized centers and can reduce the burden of open surgery in many cases. The overall volume base remains large: According to the U.S. Centers for Disease Control and Prevention (CDC, stroke information updated during 2023-2024), stroke affects hundreds of thousands of people each year in the United States, keeping emergency stroke workflows active and supporting steady use of neurovascular devices in hospitals that can treat complex cases. Access factors also keep improving because stroke systems continue to formalize routing and care networks: According to state health department stroke-system plans and EMS destination protocol updates published during 2020-2024, more regions have implemented structured triage rules that direct severe stroke patients to higher-capability stroke centers, which increases the number of hemorrhagic cases evaluated for endovascular repair using coils, stents, and flow-diversion technologies. In purchasing terms, this pushes demand toward devices that can navigate difficult anatomy, simplify procedure steps, and reduce complications that extend ICU stays.

Clinical needs also differ based on whether bleeding occurs inside the brain tissue or around the brain, and this affects which tools are required and how quickly definitive treatment must happen. The broader disease burden remains serious globally: According to World Health Organization (WHO, updates released during 2022-2024), stroke continues to rank among the top causes of death worldwide, and long-term drivers such as hypertension and aging populations keep the risk environment high. Hospital workflow pressure supports faster diagnosis and treatment readiness: According to the U.S. Centers for Medicare & Medicaid Services (CMS) inpatient and quality program updates released during 2020-2024, hospitals operate under ongoing quality and reporting expectations that reinforce standardized acute-care processes, which support investment in stroke-team capability and procedure-ready device availability. For hospital committees and neurointerventional teams, this generally translates into demand for device platforms that improve speed and consistency during aneurysm securing and reduce the risk of re-bleeding and procedure-related complications.

Hemorrhagic Stroke Treatment Devices Market- Geographical Insights

Geographically, demand for hemorrhagic stroke treatment devices tends to be higher in healthcare systems that have organized stroke networks and enough specialized hospitals to run neurointerventional services around the clock. North America and parts of Europe generally benefit from established triage systems and strong hospital spending on advanced procedures, while Asia-Pacific has a large patient base and is expanding higher-level hospital capabilities in major cities. The size of the clinical need remains a major baseline driver: According to the U.S. Centers for Disease Control and Prevention (CDC, updates published during 2023-2024), stroke affects hundreds of thousands of people each year in the United States, which supports consistent demand for aneurysm-repair tools and other neurovascular devices in stroke-capable hospitals. The global burden also stays significant: According to World Health Organization (WHO, updates released during 2022-2024), stroke remains among the top causes of death worldwide, keeping long-term pressure on emergency care capacity and the devices used to treat high-acuity bleeding events.

United States Hemorrhagic Stroke Treatment Devices Market- Country Insights

The United States stands out as a strong country market because of scale, strong reimbursement capacity, and a large base of hospitals that maintain stroke readiness and can adopt newer endovascular technologies. High stroke burden continues to support procedure activity: According to CDC (2023-2024 stroke updates), stroke remains a leading cause of serious disability and still impacts hundreds of thousands of people per year, which keeps hospital investment focused on faster diagnosis and intervention capability. Hospital incentives and workflow standards also influence procurement: According to the U.S. Centers for Medicare & Medicaid Services (CMS) inpatient payment and quality-program updates released during 2020-2024, hospitals operate under ongoing reporting and performance expectations that reinforce standardized acute stroke pathways, supporting purchasing of endovascular device inventories and surgical tools needed for hemorrhagic stroke care.

Hemorrhagic Stroke Treatment Devices Market- Competitive Landscape:

The competitive landscape is led by companies with deep neurovascular portfolios and strong clinical support, since success depends on evidence, physician training, and consistent device performance in complex anatomy. Medtronic plc and Stryker Corporation are often referenced for broad neurovascular product lines and strong positioning in major stroke centers, which helps with hospital standardization and contracting. Terumo Corporation and MicroVention, Inc. are typically linked with catheter and coil systems designed for controlled deployment and access in challenging vessels. Penumbra, Inc. is commonly associated with aspiration and procedure-support systems used in neurointervention settings where speed matters. Boston Scientific Corporation, Abbott Laboratories, and Johnson & Johnson Services, Inc. are usually seen as large-scale competitors with distribution strength and clinical infrastructure, supporting adoption across wider hospital networks. Across these vendors, competitive strength generally comes down to device deliverability, complication management, training programs, and post-market clinical data, which are the main factors used by hospital committees when selecting hemorrhagic stroke treatment platforms.

Recent Developments:

In November 2024, AIIMS Delhi and a consortium of 16 Indian hospitals (public and private hospitals providing advanced stroke care) partnered to launch the GRASSROOT clinical trial to evaluate Gravity Medical Technology's (stroke treatment device developer) stent-retriever designed for mechanical thrombectomy in Indian patients with large vessel occlusion stroke; the program was positioned around India's high stroke burden of about 1.7 million strokes annually, an estimated 375,000 patients who could benefit each year from interventional stroke treatment, and the gap that only about 4,500-5,000 patients received thrombectomy in 2023 due to access and cost, with a stated goal to bring device pricing down to roughly one-quarter of current levels.

In May 2024, IIIT Bangalore (research and engineering institute) unveiled XoRehab (an IoT-enabled rehabilitation wheelchair device) developed through the Centre for the Internet of Ethical Things with support from government and international partners, designed to help stroke patients continue physiotherapy after hospital discharge using surface EMG tracking and a 9-degree-of-freedom assistive suit for upper and lower limb movement; the device was positioned for hospital purchase at around ₹85,000-₹90,000 with a rental model to improve access for patients who struggle to attend frequent in-person therapy sessions.

In September 2021, Hyperfine, Inc. (medical imaging technology company) announced results from a Yale New Haven Hospital study of its FDA-cleared portable MRI system Swoop, showing performance for hemorrhagic stroke detection including 96.6% specificity (85/88) for blood-negative cases and 80.4% sensitivity (45/56) for intracerebral hemorrhage detection across 144 exams, with later-study software versions reaching 90.5% overall accuracy and 85.3% sensitivity (29/34); the company highlighted the bedside design as a way to reduce ICU patient transport risks and support faster stroke assessment where conventional CT/MRI access is limited.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HEMORRHAGIC STROKE TREATMENT DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • B. Braun SE
  • Balt USA, LLC
  • Boston Scientific Corporation
  • Cook Medical LLC
  • Integer Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • Kaneka Corporation
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroVention, Inc.
  • Natus Medical Incorporated
  • Nihon Kohden Corporation
  • Penumbra, Inc.
  • Phenox GmbH
  • Rapid Medical Ltd.
  • Stryker Corporation
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.
  • Wallaby Medical Holding, Inc.
  • Others

GLOBAL HEMORRHAGIC STROKE TREATMENT DEVICES MARKET, BY DEVICE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Aneurysm Coiling Devices
  • Flow Diverters
  • Aneurysm Clips
  • Stent-Assisted Coiling Systems
  • Aspiration & Thrombectomy Systems

GLOBAL HEMORRHAGIC STROKE TREATMENT DEVICES MARKET, BY STROKE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Intracerebral Hemorrhage (ICH)
  • Subarachnoid Hemorrhage (SAH)

GLOBAL HEMORRHAGIC STROKE TREATMENT DEVICES MARKET, BY PROCEDURE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Endovascular Procedures
  • Surgical Procedures

GLOBAL HEMORRHAGIC STROKE TREATMENT DEVICES MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers

GLOBAL HEMORRHAGIC STROKE TREATMENT DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Hemorrhagic Stroke Treatment Devices Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Hemorrhagic Stroke Treatment Devices Market Snippet by Device Type
    • 2.1.2. Hemorrhagic Stroke Treatment Devices Market Snippet by Stroke Type
    • 2.1.3. Hemorrhagic Stroke Treatment Devices Market Snippet by Procedure Type
    • 2.1.4. Hemorrhagic Stroke Treatment Devices Market Snippet by End User
    • 2.1.5. Hemorrhagic Stroke Treatment Devices Market Snippet by Country
    • 2.1.6. Hemorrhagic Stroke Treatment Devices Market Snippet by Region
  • 2.2. Competitive Insights

3. Hemorrhagic Stroke Treatment Devices Key Market Trends

  • 3.1. Hemorrhagic Stroke Treatment Devices Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Hemorrhagic Stroke Treatment Devices Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Hemorrhagic Stroke Treatment Devices Market Opportunities
  • 3.4. Hemorrhagic Stroke Treatment Devices Market Future Trends

4. Hemorrhagic Stroke Treatment Devices Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Hemorrhagic Stroke Treatment Devices Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Hemorrhagic Stroke Treatment Devices Market Landscape

  • 6.1. Hemorrhagic Stroke Treatment Devices Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Hemorrhagic Stroke Treatment Devices Market - By Device Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Device Type, 2024 & 2032 (%)
    • 7.1.2. Aneurysm Coiling Devices
    • 7.1.3. Flow Diverters
    • 7.1.4. Aneurysm Clips
    • 7.1.5. Stent-Assisted Coiling Systems
    • 7.1.6. Aspiration & Thrombectomy Systems

8. Hemorrhagic Stroke Treatment Devices Market - By Stroke Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Stroke Type, 2024 & 2032 (%)
    • 8.1.2. Intracerebral Hemorrhage (ICH)
    • 8.1.3. Subarachnoid Hemorrhage (SAH)

9. Hemorrhagic Stroke Treatment Devices Market - By Procedure Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Procedure Type, 2024 & 2032 (%)
    • 9.1.2. Endovascular Procedures
    • 9.1.3. Surgical Procedures

10. Hemorrhagic Stroke Treatment Devices Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Stroke Type, 2024 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Specialty Clinics
    • 10.1.4. Ambulatory Surgical Centers

11. Hemorrhagic Stroke Treatment Devices Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Hemorrhagic Stroke Treatment Devices Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Hemorrhagic Stroke Treatment Devices Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Hemorrhagic Stroke Treatment Devices Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Hemorrhagic Stroke Treatment Devices Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Hemorrhagic Stroke Treatment Devices Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Hemorrhagic Stroke Treatment Devices Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Abbott Laboratories
    • 12.2.2. B. Braun SE
    • 12.2.3. Balt USA, LLC
    • 12.2.4. Boston Scientific Corporation
    • 12.2.5. Cook Medical LLC
    • 12.2.6. Integer Holdings Corporation
    • 12.2.7. Johnson & Johnson Services, Inc.
    • 12.2.8. Kaneka Corporation
    • 12.2.9. Medtronic plc
    • 12.2.10. Merit Medical Systems, Inc.
    • 12.2.11. MicroVention, Inc.
    • 12.2.12. Natus Medical Incorporated
    • 12.2.13. Nihon Kohden Corporation
    • 12.2.14. Penumbra, Inc.
    • 12.2.15. Phenox GmbH
    • 12.2.16. Rapid Medical Ltd.
    • 12.2.17. Stryker Corporation
    • 12.2.18. Terumo Corporation
    • 12.2.19. W. L. Gore & Associates, Inc.
    • 12.2.20. Wallaby Medical Holding, Inc.
    • 12.2.21. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us